EasyManua.ls Logo

sorin REPLY DR - Contraindications; Generalities; Potential Complications

sorin REPLY DR
252 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
Pulse width ................................................................. 19
Sensitivity ................................................................... 19
Pacing and sensing polarities ..................................... 19
7.4. Refractory periods ............................................................ 20
Absolute refractory periods ........................................ 20
Committed period ....................................................... 20
Automatic AV delay .................................................... 20
AVD Paced/Sensed Offset ......................................... 21
7.5. Rate response .................................................................. 21
7.6. Therapeutic improvements .............................................. 22
SafeR mode ................................................................ 22
Dplus mode ................................................................ 22
Rate acceleration........................................................ 23
AV delay shortening ................................................... 23
Rest rate ..................................................................... 23
Rate smoothing .......................................................... 24
7.7. Managing atrial arrhythmias (AA) .................................... 25
Preventing AA: Overdrive ........................................... 25
Preventing AA: Post extrasystolic pause suppression25
Preventing AA: Acceleration on PAC ......................... 26
Protecting the ventricles against AA: Mode switching 26
7.8. Optimizing operation ........................................................ 27
Automatic detection of implantation ........................... 27
Autosensing ................................................................ 28
Ventricular Auto-threshold .......................................... 29
Anti-PMT protection .................................................... 29
8. Patient follow-up ...................................................................... 30
8.1. Follow-up recommendations ............................................ 30
8.2. Elective Replacement Indicator (ERI) .............................. 30
8.3. Explant ............................................................................. 31
8.4. Programmer tests ............................................................ 32
8.5. Interrogating the memories (AIDA+) ................................ 32
8.6. Pacemaker identification .................................................. 33

Table of Contents

Related product manuals